Selected research
Market Outlook & Growth Opportunities
Global Blockchain in Pharmaceutical Supply Chain Market Outlook and Growth Opportunities 2026
Market perspective
The global Blockchain in Pharmaceutical Supply Chain market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Blockchain in Pharmaceutical Supply Chain is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Blockchain in Pharmaceutical Supply Chain is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Blockchain in Pharmaceutical Supply Chain is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Blockchain in Pharmaceutical Supply Chain market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Blockchain in Pharmaceutical Supply Chain market include Amazon Web Services, Chronicled, Doc.AI, Embleema, Factom Protocol, FarmaTrust, Guardtime Federal, Hashed Health and Huawei, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Blockchain in Pharmaceutical Supply Chain market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Blockchain in Pharmaceutical Supply Chain and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Blockchain in Pharmaceutical Supply Chain revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Blockchain in Pharmaceutical Supply Chain market.
Blockchain in Pharmaceutical Supply Chain Segment by Company
Amazon Web Services
Chronicled
Doc.AI
Embleema
Factom Protocol
FarmaTrust
Guardtime Federal
Hashed Health
Huawei
IBM
Medicalchain
Microsoft
SAP
Blockchain in Pharmaceutical Supply Chain Segment by Type
Private Blockchain
Public Blockchain
Consortium Blockchain
Blockchain in Pharmaceutical Supply Chain Segment by Application
Drug Development and Clinical Trials
Logistics and Warehousing Management
Drug Authenticity Verification
Others
Blockchain in Pharmaceutical Supply Chain Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Blockchain in Pharmaceutical Supply Chain status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Blockchain in Pharmaceutical Supply Chain key companies, revenue, market share, and recent developments.
3. To split the Blockchain in Pharmaceutical Supply Chain breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Blockchain in Pharmaceutical Supply Chain market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Blockchain in Pharmaceutical Supply Chain significant trends, drivers, influence factors in global and regions.
6. To analyze Blockchain in Pharmaceutical Supply Chain competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blockchain in Pharmaceutical Supply Chain market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blockchain in Pharmaceutical Supply Chain and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blockchain in Pharmaceutical Supply Chain.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blockchain in Pharmaceutical Supply Chain industry.
Chapter 3: Detailed analysis of Blockchain in Pharmaceutical Supply Chain company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Blockchain in Pharmaceutical Supply Chain in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Blockchain in Pharmaceutical Supply Chain in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Private Blockchain
- Public Blockchain
- Consortium Blockchain
Applications
- Drug Development and Clinical Trials
- Logistics and Warehousing Management
- Drug Authenticity Verification
- Others
Companies covered
- Amazon Web Services
- Chronicled
- Doc.AI
- Embleema
- Factom Protocol
- FarmaTrust
- Guardtime Federal
- Hashed Health
- Huawei
- IBM
- Medicalchain
- Microsoft
- SAP
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Blockchain in Pharmaceutical Supply Chain Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Blockchain in Pharmaceutical Supply Chain Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Blockchain in Pharmaceutical Supply Chain Market Dynamics
- 2.1 Blockchain in Pharmaceutical Supply Chain Industry Trends
- 2.2 Blockchain in Pharmaceutical Supply Chain Industry Drivers
- 2.3 Blockchain in Pharmaceutical Supply Chain Industry Opportunities and Challenges
- 2.4 Blockchain in Pharmaceutical Supply Chain Industry Restraints
3 Blockchain in Pharmaceutical Supply Chain Market by Company
- 3.1 Global Blockchain in Pharmaceutical Supply Chain Company Revenue Ranking in 2025
- 3.2 Global Blockchain in Pharmaceutical Supply Chain Revenue by Company (2021-2026)
- 3.3 Global Blockchain in Pharmaceutical Supply Chain Company Ranking (2024-2026)
- 3.4 Global Blockchain in Pharmaceutical Supply Chain Company Manufacturing Base and Headquarters
- 3.5 Global Blockchain in Pharmaceutical Supply Chain Company Product Type and Application
- 3.6 Global Blockchain in Pharmaceutical Supply Chain Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Blockchain in Pharmaceutical Supply Chain Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Blockchain in Pharmaceutical Supply Chain Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Blockchain in Pharmaceutical Supply Chain Market by Type
- 4.1 Blockchain in Pharmaceutical Supply Chain Type Introduction
- 4.1.1 Private Blockchain
- 4.1.2 Public Blockchain
- 4.1.3 Consortium Blockchain
- 4.2 Global Blockchain in Pharmaceutical Supply Chain Sales Value by Type
- 4.2.1 Global Blockchain in Pharmaceutical Supply Chain Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Blockchain in Pharmaceutical Supply Chain Sales Value by Type (2021-2032)
- 4.2.3 Global Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type (2021-2032)
5 Blockchain in Pharmaceutical Supply Chain Market by Application
- 5.1 Blockchain in Pharmaceutical Supply Chain Application Introduction
- 5.1.1 Drug Development and Clinical Trials
- 5.1.2 Logistics and Warehousing Management
- 5.1.3 Drug Authenticity Verification
- 5.1.4 Others
- 5.2 Global Blockchain in Pharmaceutical Supply Chain Sales Value by Application
- 5.2.1 Global Blockchain in Pharmaceutical Supply Chain Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Blockchain in Pharmaceutical Supply Chain Sales Value by Application (2021-2032)
- 5.2.3 Global Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application (2021-2032)
6 Blockchain in Pharmaceutical Supply Chain Regional Value Analysis
- 6.1 Global Blockchain in Pharmaceutical Supply Chain Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Blockchain in Pharmaceutical Supply Chain Sales Value by Region (2021-2032)
- 6.2.1 Global Blockchain in Pharmaceutical Supply Chain Sales Value by Region: 2021-2026
- 6.2.2 Global Blockchain in Pharmaceutical Supply Chain Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Blockchain in Pharmaceutical Supply Chain Sales Value (2021-2032)
- 6.3.2 North America Blockchain in Pharmaceutical Supply Chain Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Blockchain in Pharmaceutical Supply Chain Sales Value (2021-2032)
- 6.4.2 Europe Blockchain in Pharmaceutical Supply Chain Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Blockchain in Pharmaceutical Supply Chain Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Blockchain in Pharmaceutical Supply Chain Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Blockchain in Pharmaceutical Supply Chain Sales Value (2021-2032)
- 6.6.2 South America Blockchain in Pharmaceutical Supply Chain Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Blockchain in Pharmaceutical Supply Chain Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Blockchain in Pharmaceutical Supply Chain Sales Value Share by Country, 2025 VS 2032
7 Blockchain in Pharmaceutical Supply Chain Country-level Value Analysis
- 7.1 Global Blockchain in Pharmaceutical Supply Chain Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Blockchain in Pharmaceutical Supply Chain Sales Value by Country (2021-2032)
- 7.2.1 Global Blockchain in Pharmaceutical Supply Chain Sales Value by Country (2021-2026)
- 7.2.2 Global Blockchain in Pharmaceutical Supply Chain Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.7.2 France Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.14.2 China Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.17.2 India Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Blockchain in Pharmaceutical Supply Chain Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Blockchain in Pharmaceutical Supply Chain Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Blockchain in Pharmaceutical Supply Chain Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Amazon Web Services
- 8.1.1 Amazon Web Services Company Information
- 8.1.2 Amazon Web Services Business Overview
- 8.1.3 Amazon Web Services Blockchain in Pharmaceutical Supply Chain Revenue and Gross Margin (2021-2026)
- 8.1.4 Amazon Web Services Blockchain in Pharmaceutical Supply Chain Product Portfolio
- 8.1.5 Amazon Web Services Recent Developments
- 8.2 Chronicled
- 8.2.1 Chronicled Company Information
- 8.2.2 Chronicled Business Overview
- 8.2.3 Chronicled Blockchain in Pharmaceutical Supply Chain Revenue and Gross Margin (2021-2026)
- 8.2.4 Chronicled Blockchain in Pharmaceutical Supply Chain Product Portfolio
- 8.2.5 Chronicled Recent Developments
- 8.3 Doc.AI
- 8.3.1 Doc.AI Company Information
- 8.3.2 Doc.AI Business Overview
- 8.3.3 Doc.AI Blockchain in Pharmaceutical Supply Chain Revenue and Gross Margin (2021-2026)
- 8.3.4 Doc.AI Blockchain in Pharmaceutical Supply Chain Product Portfolio
- 8.3.5 Doc.AI Recent Developments
- 8.4 Embleema
- 8.4.1 Embleema Company Information
- 8.4.2 Embleema Business Overview
- 8.4.3 Embleema Blockchain in Pharmaceutical Supply Chain Revenue and Gross Margin (2021-2026)
- 8.4.4 Embleema Blockchain in Pharmaceutical Supply Chain Product Portfolio
- 8.4.5 Embleema Recent Developments
- 8.5 Factom Protocol
- 8.5.1 Factom Protocol Company Information
- 8.5.2 Factom Protocol Business Overview
- 8.5.3 Factom Protocol Blockchain in Pharmaceutical Supply Chain Revenue and Gross Margin (2021-2026)
- 8.5.4 Factom Protocol Blockchain in Pharmaceutical Supply Chain Product Portfolio
- 8.5.5 Factom Protocol Recent Developments
- 8.6 FarmaTrust
- 8.6.1 FarmaTrust Company Information
- 8.6.2 FarmaTrust Business Overview
- 8.6.3 FarmaTrust Blockchain in Pharmaceutical Supply Chain Revenue and Gross Margin (2021-2026)
- 8.6.4 FarmaTrust Blockchain in Pharmaceutical Supply Chain Product Portfolio
- 8.6.5 FarmaTrust Recent Developments
- 8.7 Guardtime Federal
- 8.7.1 Guardtime Federal Company Information
- 8.7.2 Guardtime Federal Business Overview
- 8.7.3 Guardtime Federal Blockchain in Pharmaceutical Supply Chain Revenue and Gross Margin (2021-2026)
- 8.7.4 Guardtime Federal Blockchain in Pharmaceutical Supply Chain Product Portfolio
- 8.7.5 Guardtime Federal Recent Developments
- 8.8 Hashed Health
- 8.8.1 Hashed Health Company Information
- 8.8.2 Hashed Health Business Overview
- 8.8.3 Hashed Health Blockchain in Pharmaceutical Supply Chain Revenue and Gross Margin (2021-2026)
- 8.8.4 Hashed Health Blockchain in Pharmaceutical Supply Chain Product Portfolio
- 8.8.5 Hashed Health Recent Developments
- 8.9 Huawei
- 8.9.1 Huawei Company Information
- 8.9.2 Huawei Business Overview
- 8.9.3 Huawei Blockchain in Pharmaceutical Supply Chain Revenue and Gross Margin (2021-2026)
- 8.9.4 Huawei Blockchain in Pharmaceutical Supply Chain Product Portfolio
- 8.9.5 Huawei Recent Developments
- 8.10 IBM
- 8.10.1 IBM Company Information
- 8.10.2 IBM Business Overview
- 8.10.3 IBM Blockchain in Pharmaceutical Supply Chain Revenue and Gross Margin (2021-2026)
- 8.10.4 IBM Blockchain in Pharmaceutical Supply Chain Product Portfolio
- 8.10.5 IBM Recent Developments
- 8.11 Medicalchain
- 8.11.1 Medicalchain Company Information
- 8.11.2 Medicalchain Business Overview
- 8.11.3 Medicalchain Blockchain in Pharmaceutical Supply Chain Revenue and Gross Margin (2021-2026)
- 8.11.4 Medicalchain Blockchain in Pharmaceutical Supply Chain Product Portfolio
- 8.11.5 Medicalchain Recent Developments
- 8.12 Microsoft
- 8.12.1 Microsoft Company Information
- 8.12.2 Microsoft Business Overview
- 8.12.3 Microsoft Blockchain in Pharmaceutical Supply Chain Revenue and Gross Margin (2021-2026)
- 8.12.4 Microsoft Blockchain in Pharmaceutical Supply Chain Product Portfolio
- 8.12.5 Microsoft Recent Developments
- 8.13 SAP
- 8.13.1 SAP Company Information
- 8.13.2 SAP Business Overview
- 8.13.3 SAP Blockchain in Pharmaceutical Supply Chain Revenue and Gross Margin (2021-2026)
- 8.13.4 SAP Blockchain in Pharmaceutical Supply Chain Product Portfolio
- 8.13.5 SAP Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst